We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ADVANCIS, PAR SIGN DEAL TO DEVELOP NEW ANTIBIOTIC DRUG
ADVANCIS, PAR SIGN DEAL TO DEVELOP NEW ANTIBIOTIC DRUG
June 15, 2004
Generic firm Par Pharmaceutical and brand drugmaker Advancis Pharmaceutical on June 2 finalized an agreement to develop and co-promote a new branded version of the widely used generic antibiotic amoxicillin.